Profile
Sector:
HealthcareIndustry:
Medical DevicesCountry:
United StatesIPO:
28 May 2015Website:
http://www.nanovibronix.comNext earnings report:
09 August 2024Last dividends:
N/ANext dividends:
N/APrice
regular market | 12 min agoDividend
Analysts recommendations
Institutional Ownership
What type of business is NanoVibronix?
NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its principal products include UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use; PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device, which facilitates tissue regeneration and wound healing. The company sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, India, and internationally. NanoVibronix, Inc. was incorporated in 2003 and is based in Elmsford, New York.
What sector is NanoVibronix in?
NanoVibronix is in the Healthcare sector
What industry is NanoVibronix in?
NanoVibronix is in the Medical Devices industry
What country is NanoVibronix from?
NanoVibronix is headquartered in United States
When did NanoVibronix go public?
NanoVibronix initial public offering (IPO) was on 28 May 2015
What is NanoVibronix website?
https://www.nanovibronix.com
Is NanoVibronix in the S&P 500?
No, NanoVibronix is not included in the S&P 500 index
Is NanoVibronix in the NASDAQ 100?
No, NanoVibronix is not included in the NASDAQ 100 index
Is NanoVibronix in the Dow Jones?
No, NanoVibronix is not included in the Dow Jones index
When does NanoVibronix report earnings?
The next expected earnings date for NanoVibronix is 09 August 2024